Filing Details

Accession Number:
0001415889-24-025393
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-17 18:34:47
Reporting Period:
2024-10-15
Accepted Time:
2024-10-17 18:34:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1736730 Camp4 Therapeutics Corp CAMP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1867470 Northpond Ventures Gp, Llc 7500 Old Georgetown Road, Suite 800
Bethesda MD 20814
No No Yes No
1867472 Northpond Ventures, Lp 7500 Old Georgetown Road, Suite 800
Bethesda MD 20814
No No Yes No
1867627 P. Michael Rubin C/O Northpond Ventures
7500 Old Georgetown Road, Suite 800
Bethesda MD 20814
No No Yes No
1869114 Northpond Ventures Ii Gp, Llc 7500 Old Georgetown Road, Suite 800
Bethesda MD 20814
No No No No
1869128 Northpond Ventures Ii, Lp 7500 Old Georgetown Road, Suite 800
Bethesda MD 20814
No No Yes No
1972690 Northpond Ventures Iii, Lp 7500 Old Georgetown Road, Suite 800
Bethesda MD 20814
No No Yes No
2010695 Northpond Ventures Iii Gp, Llc 7500 Old Georgetown Road, Suite 800
Bethesda MD 20814
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-10-15 1,003,193 $0.00 1,003,193 No 4 C Indirect By Northpond Ventures II, LP
Common Stock Acquisiton 2024-10-15 471,415 $0.00 471,415 No 4 C Indirect By Northpond Ventures, LP
Common Stock Acquisiton 2024-10-15 763,636 $11.00 763,636 No 4 P Indirect By Northpond Ventures III, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Northpond Ventures II, LP
No 4 C Indirect By Northpond Ventures, LP
No 4 P Indirect By Northpond Ventures III, LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Prime Preferred Stock Disposition 2024-10-15 11,251,624 $0.00 1,003,193 $0.00
Common Stock Series B Preferred Stock Disposition 2024-10-15 5,287,303 $0.00 471,415 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
  2. The shares are held directly by Northpond Ventures II, LP ("Northpond Fund II"). Northpond Ventures II GP, LLC ("Northpond II GP") is the general partner of Northpond Fund II, and Michael P. Rubin is the managing member of Northpond II GP. As a result, each of Northpond II GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond II GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
  3. The shares are held directly by Northpond Ventures, LP ("Northpond Fund I"). Northpond Ventures GP, LLC ("Northpond GP I") is the general partner of Northpond Fund I, and Michael P. Rubin is the managing member of Northpond GP I. As a result, each of Northpond GP I and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund I. Each of Northpond GP I and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
  4. The shares are held directly by Northpond Ventures III, LP ("Northpond Fund III"). Northpond Ventures III GP, LLC ("Northpond III GP") is the general partner of Northpond Fund III, and Michael P. Rubin is the managing member of Northpond III GP. As a result, each of Northpond III GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund III. Each of Northpond III GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.